Insights from project could potentially improve precision medicine use for paediatric AML
Insights from project could potentially improve precision medicine use for paediatric AML
Drug is being investigated in up to 800 hospitalised patients nationwide
Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis
Pharma industry bodies call for medicine supply to be safeguarded in upcoming talks
Zercepac will be available for HER2-positive breast and gastric cancers
ICR and Cancer Research UK spinout closes Series B financing
Survey commissioned by Johnson & Johnson for World Pharmacists Day
Trial is being conducted in partnership with UK government’s Vaccines Taskforce
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
Phase III trial programme will evaluate nebulised ensifentrine in moderate-to-severe COPD
UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis
App will automatically alert users when they come into close contact with someone with the virus
European Medicines Agency grants designation based on phase I/II data
The Leeds Dementia Pathfinder project supported patients and carers with tech devices
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis